[Targeted HCC therapies: the door has been opened!]

Gastroenterol Clin Biol. 2008 Jan;32(1 Pt. 1):1-2. doi: 10.1016/j.gcb.2007.12.001. Epub 2008 Mar 4.
[Article in French]
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Carcinoma, Hepatocellular / drug therapy*
  • ErbB Receptors / antagonists & inhibitors
  • Humans
  • Liver Neoplasms / drug therapy*
  • Protein Kinase Inhibitors / therapeutic use
  • Receptors, Vascular Endothelial Growth Factor / antagonists & inhibitors

Substances

  • Antineoplastic Agents
  • Protein Kinase Inhibitors
  • ErbB Receptors
  • Receptors, Vascular Endothelial Growth Factor